NASEM Hosts Chronic Illness Workshop with Key ME/CFS Voices

The National Academies of Sciences, Engineering, and Medicine (NASEM) is hosting a two-day workshop bringing together clinicians, researchers, and other stakeholders to create a scientific paradigm shift by examining common […]
Sen. Tim Kaine Shares His Long Covid Experience at Solve Event, Calls for More Research and Equitable Care

Solve recently co-hosted with BIO the event “Long Covid: What Will It Take to Accelerate Therapeutic Progress?,” convening stakeholders to advance research and development to diagnose and treat Long Covid, […]
New Studies Point to a Signature for ME/CFS: Will They Lead to Widely Used Diagnostic Tests?

By Oved Amitay, Solve M.E. President and CEO Three studies were published last week, describing incredibly intriguing data, each pointing to specific biomarkers that can help to identify people with […]
New Findings Alert! NIH-Funded Studies Link Altered Gut Microbes to ME/CFS

Recently released papers with findings from two National Institutes of Health-funded studies by the Center for Solutions for ME/CFS & The Jackson Laboratory indicate that microbiome changes may be a […]
Solve, BIO Online Conference Invites Biotech to Join In Fighting Long Covid

This article by Tom Popper originally appeared on Bio.com. While research into Long Covid is offering clues to causes and potential targets for treatment, defeating this debilitating condition, which impacts […]
Solve and World ME Alliance Address Health Equity Disparities in Letter to WHO

We joined 20 other members of the World ME Alliance in writing to the World Health Organization (WHO) highlighting significant gaps in their recent report on health equity for persons […]
Ramsay Grant Program 2022 RFA is Open!

Solve M.E. is accepting applications to study ME/CFS and Long Covid from April 9 – May 23, 2022. Through the Ramsay Program, Solve M.E. invests in research studies in ME/CFS or […]
Solve M.E. co-authors whitepaper “Long Covid Impact on Adult Americans: Early Indicators Estimating Prevalence and Cost”

This week, Solve M.E. invited members of the press to a special event announcing the release of our new whitepaper, Long Covid Impact on Adult Americans: Early Indicators Estimating Prevalence […]
President Biden Signs FY22 Budget: Wins for ME/CFS and Long Covid

Support Research, Support Patients A recent survey from our friends at Research!America found that over 80% of Americans believe our government should fund “basic scientific research that advances the frontiers […]
“The Long Covid Bust” – A Working Caregiver’s Perspective

By Emily Taylor, Vice President of Advocacy and Community Engagement, Solve M.E. This essay was originally published as a blog for Cumberland Advisors Market Commentary “I just got a virus, […]
After Vaccination, Health of People with Long Covid More Likely to Improve or Worsen Compared to Controls

In survey, 30% of people with Long Covid said health improved after vaccination and 28% said health worsened, compared to 4% and 7%, respectively, reported by controls December 21, 2021–With […]